Your browser doesn't support javascript.
loading
Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen.
Menden, Michael P; Wang, Dennis; Mason, Mike J; Szalai, Bence; Bulusu, Krishna C; Guan, Yuanfang; Yu, Thomas; Kang, Jaewoo; Jeon, Minji; Wolfinger, Russ; Nguyen, Tin; Zaslavskiy, Mikhail; Jang, In Sock; Ghazoui, Zara; Ahsen, Mehmet Eren; Vogel, Robert; Neto, Elias Chaibub; Norman, Thea; Tang, Eric K Y; Garnett, Mathew J; Veroli, Giovanni Y Di; Fawell, Stephen; Stolovitzky, Gustavo; Guinney, Justin; Dry, Jonathan R; Saez-Rodriguez, Julio.
Afiliação
  • Menden MP; Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, SG8 6EH, UK.
  • Wang D; European Bioinformatics Institute, European Molecular Biology Laboratory, Cambridge, CB10 1SD, UK.
  • Mason MJ; Institute of Computational Biology, Helmholtz Zentrum München - German Research Center for Environmental Health, Munich, D-85764, Germany.
  • Szalai B; Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, SG8 6EH, UK.
  • Bulusu KC; Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, S10 2TN, UK.
  • Guan Y; Sage Bionetworks, Seattle, WA, 98121, USA.
  • Yu T; Department of Physiology, Faculty of Medicine, Semmelweis University, Budapest, 1085, Hungary.
  • Kang J; Laboratory of Molecular Physiology, Hungarian Academy of Sciences and Semmelweis University (MTA-SE), Budapest, 1085, Hungary.
  • Jeon M; RWTH Aachen University, Faculty of Medicine, Joint Research Center for Computational Biomedicine, Aachen, 52062, Germany.
  • Wolfinger R; Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, SG8 6EH, UK.
  • Nguyen T; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, 48109, USA.
  • Zaslavskiy M; Sage Bionetworks, Seattle, WA, 98121, USA.
  • Jang IS; Department of Computer Science and Engineering, Korea University, Seoul, 02841, Korea.
  • Ghazoui Z; SAS Institute, Inc, Cary, NC, 27513, USA.
  • Ahsen ME; Department of Computer Science and Engineering, University of Nevada, Reno, 89557, USA.
  • Vogel R; Independent Consultant in Computational Biology, Owkin, Inc., New York, NY, 10022, USA.
  • Norman T; Sage Bionetworks, Seattle, WA, 98121, USA.
  • Tang EKY; Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, SG8 6EH, UK.
  • Garnett MJ; IBM Thomas J. Watson Research Center, Yorktown Heights, New York, 10598, USA.
  • Veroli GYD; IBM Thomas J. Watson Research Center, Yorktown Heights, New York, 10598, USA.
  • Fawell S; Sage Bionetworks, Seattle, WA, 98121, USA.
  • Stolovitzky G; Sage Bionetworks, Seattle, WA, 98121, USA.
  • Guinney J; Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, SG8 6EH, UK.
  • Dry JR; Wellcome Trust Sanger Institute, Hinxton, CB10 1SA, UK.
  • Saez-Rodriguez J; Early Clinical Development, IMED Biotech Unit, AstraZeneca, Cambridge, SG8 6EH, UK.
Nat Commun ; 10(1): 2674, 2019 06 17.
Article em En | MEDLINE | ID: mdl-31209238
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Farmacogenética / Protocolos de Quimioterapia Combinada Antineoplásica / Biologia Computacional / Neoplasias Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Farmacogenética / Protocolos de Quimioterapia Combinada Antineoplásica / Biologia Computacional / Neoplasias Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido